Alnylam Pharmace. buy JPMorgan Chase & Co.
Start price
24.03.25
/
50%
€270.10
Target price
24.03.26
€302.97
Performance (%)
-3.00%
End price
25.03.26
€262.00
Summary
This prediction ended on 25.03.26 with a price of €262.00. With a performance of -3.00%, the BUY prediction for Alnylam Pharmace. by JPMorgan_Chase___Co_ closed slightly in the red. JPMorgan_Chase___Co_ has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 7.308% | 7.308% | -12.325% |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $328.00 price target on the stock, up previously from $280.00.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€406.80
13.10.25
13.10.25
€407.06
13.10.26
13.10.26
-38.27%
29.07.26
29.07.26
Stopped prediction by JPMorgan_Chase___Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€234.00
22.07.26
22.07.26
€350.68
22.07.27
22.07.27
7.31%
29.07.26
29.07.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€277.50
16.07.25
16.07.25
€299.70
16.07.26
16.07.26
-11.71%
17.07.26
17.07.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€264.00
12.06.25
12.06.25
€296.26
12.06.26
12.06.26
-7.54%
13.06.26
13.06.26